End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.28 USD | +0.35% |
|
+2.07% | +24.39% |
Jun. 11 | Alvotech Appoints Hjörleifur Pálsson as Director | CI |
Jun. 11 | Alvotech and STADA Arzneimittel AG Add to Strategic Alliance Through Denosumab Partnership | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.39% | 3.99B | |
+40.80% | 55.66B | |
-8.05% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.69% | 26.29B | |
-16.21% | 20.25B | |
+31.00% | 12.76B | |
+28.51% | 12.18B | |
-1.67% | 12.12B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab